Friden; Phillip M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Friden; Phillip M..The latest application filed is for "pharmaceutical formulations for iontophoretic delivery of gallium".

Company Profile

1.10.11

Friden; Phillip M. - Bedford MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Formulations for Iontophoretic Delivery of Gallium App 20130072899 - Friden; Phillip M. ; et al.	2013-03-21
Pharmaceutical Formulations for Iontophoretic Delivery of a Corticosteroid App 20110281834 - Friden; Phillip M. ; et al.	2011-11-17
Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator App 20100331812 - Friden; Phillip M. ; et al.	2010-12-30
Method Of Enhancing Iontophoretic Delivery Of A Peptide App 20090082713 - Friden; Phillip M.	2009-03-26
Pharmaceutical Formulations For Iontophoretic Delivery Of An Anti-fungal Drug App 20080261986 - Friden; Phillip M. ; et al.	2008-10-23
Pharmaceutical Formulations For Iontophoretic Drug Delivery App 20070248629 - FRIDEN; PHILLIP M. ; et al.	2007-10-25
Pharmaceutical Formulations For Iontophoretic Methotrexate Delivery App 20070248630 - Friden; Phillip M.	2007-10-25
Electrokinetic System And Method For Delivering Methotrexate App 20070185432 - Etheredge; Robert W. III ; et al.	2007-08-09
Electrokinetic delivery system and methods therefor App 20070066934 - Etheredge; Robert W. III ; et al.	2007-03-22
Method For Treating Cystic Fibrosis App 20020077282 - SPACCIAPOLI, PETER ; et al.	2002-06-20
Composite wafer for controlled drug delivery App 20020022048 - Bromberg, Lev E. ; et al.	2002-02-21
Transferrin receptor reactive chimeric antibodies Grant 6,329,508 - Friden December 11, 2	2001-12-11
Use of locally delivered metal ions for treatment of periodontal disease Grant 6,153,210 - Roberts , et al. November 28, 2	2000-11-28
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates Grant 6,015,555 - Friden January 18, 2	2000-01-18
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins Grant 5,977,307 - Friden , et al. November 2, 1	1999-11-02
Anti-fungal and anti-bacterial histatin-based peptides Grant 5,912,230 - Oppenheim , et al. June 15, 1	1999-06-15
Anti-fungal D-amino acid histatin-based peptides Grant 5,885,965 - Oppenheim , et al. March 23, 1	1999-03-23
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates Grant 5,833,988 - Friden November 10, 1	1998-11-10
Transferrin neuropharmaceutical agent fusion protein Grant 5,672,683 - Friden , et al. September 30, 1	1997-09-30
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates Grant 5,527,527 - Friden * June 18, 1	1996-06-18
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates Grant 5,182,107 - Friden * January 26, 1	1993-01-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.